$985 – $1,985

Event Information

Share this event

Date and Time

Location

Location

Hyatt Regency Boston

1 Avenue de Lafayette

Boston, MA 02111

View Map

Refund Policy

Refund Policy

No Refunds

Friends Who Are Going
Event description

Description

GTCbio and the advisory board would like to invite you to the 11th Diabetes Summit to be held April 10-11, 2018 in Boston, MA. GTCbio’s Diabetes Summit encompasses the drug discovery and partnering aspects of diabetes in three tracks.. Experts from industry and academia will discuss strategies to target Type 1 and Type 2 diabetes in presentations, panels and round-table discussions that highlight basic research novel therapeutic targets, translation to the clinic, devices and digital aids, funding and partnering trends, emerging technologies and other relevant topics.

Joint Plenary Sessions:

  1. Opening Keynote Session – Historical Perspective & Current State of the Industry
  2. Round Table Discussions
  3. Ready, Set, Grow – New Company/Technology Pitch Competition & Lunch
  4. Award Ceremony & Closing Keynote Session – Predictions for future

Track 1: Diabetes Drug Discovery & Development Conference

  1. What’s New in Type I Diabetes – Targets, Models, Assays, etc.
  2. Translational and Clinical Development for Type I Diabetes
  3. What’s New in Type II Diabetes – Targets, Models, Assays, etc.
  4. Translational and Clinical Development for Type II Diabetes

Track 2: Diabetes Partnering & Deal-Making Conference

  1. Industry Partnering with Academia and CROs to Advance Research
  2. Investments from Private, Institutional and Public Sources

Track 3: Devices and Digital Aids in Diabetes Management Conference

  1. Next Generation Glucose Monitoring Devices and Technology
  2. The Role of “Being Digitally Connected” in Diabetes Management


Day 1 – Tuesday, April 10, 2018
Registration and Breakfast
Kick-off Keynote Session – Historical Perspective and State of the Industry
Morning Networking Break
Drug Discovery and Development for Type I Diabetes Diabetes Partnering and Deal-making
What’s New in Type I Diabetes – Targets, Models, Assays, etc. Industry Partnering with Academia and CROs to Advance Research
Sponsored Lunch Workshop
Translational and Clinical Development for Type I Diabetes Investments from Private, Institutional and Public Sources
Afternoon Networking Break
Round Table Discussions
Sponsored Reception and Poster Session
Dinner with Sponsors and 2018 AB (By Invitation Only)


Day 2 – Wednesday, April 11, 2018
Breakfast with Mentors from Academia and Industry
Drug Discovery and Development for Type II Diabetes Devices and Digital Aids in Diabetes Management
What’s New in Type II Diabetes – Targets, Models, Assays, etc. Next Generation Glucose Monitoring Devices and Technology
Morning Networking Break
Translational and Clinical Development for Type II Diabetes The Role of “Being Digitally Connected” in Diabetes Management
Ready, Set, Grow – New Company/Technology Pitch Competition & Lunch
Award Ceremony and Closing Keynote Session – Predictions for the Future
Conference Closes
2019 Advisory Board Meeting (By Invitation Only)



PLENARY KEYNOTE SPEAKERS
Alan Cherrington

Alan Cherrington
Professor of Molecular Physiology and Biophysics
Vanderbilt University

Alexander (Zan) Fleming

Alexander (Zan) Fleming
President & Chief Exective Officer
Kinexum

Riccardo Perfetti

Riccardo Perfetti
Head of Global Medical Team Diabetes, Vice President Global Medical Affairs, Sanofi
Sanofi Diabetes & Cardiovascular Business Unit

PLENARY SPEAKERS
John Campbell

John Campbell
Associate Director, Research, Development & Innovation
SNBTS, National Science Laboratory

Douglas Losordo

Douglas Losordo
Chief Medical Officer, Senior Vice President of Clinical, Medical & Regulatory Affairs
Caladrius Biosciences

Felicia Pagliuca

Felicia Pagliuca
Vice President, Cell Biology R&D
Semma Therapeutics

Mark Zimmerman

Mark Zimmerman
Vice President, Strategy and Business Development
ViaCyte

Diabetes Drug Discovery & Development 2017
DISTINGUISHED SPEAKERS
Raja-Elie Abdulnour

Raja-Elie Abdulnour
Instructor of Medicine
Brigham and Women's Hospital

William W. Bachovchin

William Bachovchin
Professor, Department of Biochemistry
Tufts University School of Medicine

Robin Barbour

Robin Barbour
Senior Director Antibody and Assay Development
Prothena Biosciences Inc.

Sudha B. Biddinger

Sudha Biddinger
Associate Professor of Pediatrics
Children's Hospital of Boston

Bruno Doiron

Bruno Doiron
Assistant Professor
University of Texas Health Science Center at San Antonio

Denise Faustman

Denise Faustman
Director of the Immunobiology Laboratory at the Massachusetts General Hospital (MGH)
Associate Professor of Medicine at Harvard Medical School

Judith Gorski

Judith Gorski
Global Director, Scientific Engagement
Crown Bioscience Inc.

Jongsoon Lee

Jongsoon Lee
Assistant Professor of Medicine
Joslin Diabetes Center, Harvard Medical School

Larry Steinman

Larry Steinman
Professor, Pediatrics and Neurology
Stanford University

Pragalath Sundararajan

Pragalath Sundararajan
Scientist
BERG Health

Diabetes Partnering & Deal-Making 2017
DISTINGUISHED SPEAKERS
Mostafa Analoui

Mostafa Analoui
Executive Director
UCONN Ventures

Jonathan Behr

Jonathan Behr
Managing Director
JDFR

Richard Berenson

Richard Berenson
Chief Executive Officer
Thermalin Diabetes

Brian Bloomquist

Brian Bloomquist
Senior Director, Global External Research and Development
Eli Lilly

Laura Brandner

Laura Brandner
Manager of Global Software Innovation
Abbott

John Brooks III

John Brooks
Managing Director
Healthcare Capital LLC

MaryJulia Brosnan

MaryJulia Brosnan
Director, External Collaborations and Scientific Alliances
Pfizer

Victor Chapela

Victor Chapela
Chief Executive Officer and Co-Founder
Suggestic

Benjamin Conway

Benjamin Conway
Managing Director, Life Sciences
Consilium Partners

Shantanu Gaur

Shantanu Gaur
Co-Founder & Chief Scientific Officer
Allurion Technologies

Robert Geho

Robert Geho
Co-Founder and Chief Executive Officer
Diasome Pharmaceuticals Inc

Karin Hehenberger

Karin Hehenberger
Chief Executive Officer & Founder
LyfeBulb

Nathaniel	Kleintzman

Nathaniel Heintzman
Director, Partner Portfolio
Dexcom

Scott Johnson

Scott Johnson
Communications Lead
mySugr GmbH

Charles O'Connell

Charles O'Connell
Founder and CEO
Fitscript

Nandan Padukone

Nandan Padukone
Senior Vice President, Innovation
Joslin Diabetes Center

Steven Russell

Steven Russell
Assistant Professor of Medicine
Massachusetts General Hospital

Aaron Schwartz

Aaron Schwartz
Director, R&D Innovation Sourcing
Novo Nordisk Inc.

Omid Veiseh

Omid Veiseh
Founding Scientist and Head of Innovation
Sigilon





Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
- Discounts for multiple participants.
- Require a price quotation.
- Require to pay by wire transfer or PayPal
- Invitation letter for visa applications

NO REFUNDS ALLOWED ON REGISTRATIONS
-----------------------------------------------------------------
This Event is Brought to You by:
GTCbio - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com

MYL171011CEV
Share with friends

Date and Time

Location

Hyatt Regency Boston

1 Avenue de Lafayette

Boston, MA 02111

View Map

Refund Policy

No Refunds

Save This Event

Event Saved